Literature DB >> 23238365

Dual-energy CT to detect recurrent HCC after TACE: initial experience of color-coded iodine CT imaging.

Jeong-Ah Lee1, Woo Kyoung Jeong, Yongsoo Kim, Soon-Young Song, Jinoo Kim, Jeong Nam Heo, Choong Ki Park.   

Abstract

OBJECTIVES: To evaluate the feasibility of diagnosing recurrence of HCC after TACE color-coded iodine CT (CICT) based on arterial phase scans obtained by a dual-energy CT (DECT) scanner.
METHODS: A CICT scan was acquired from an iodine map after applying material decomposition of the liver tissue and setting a threshold attenuation level for viable tumors. Two radiologists reviewed both conventional and CICT sets in 31 patients who had a history of TACE for HCC. The performances in detecting local tumor progression (LTP) were evaluated by alternative free-response receiver operating characteristics. The rate of uncertain diagnosis and interobserver agreement of the diagnosis were explored. Additionally, the reading time and radiation dose were also investigated.
RESULTS: The mean figures of merit of the conventional and CICT sets for LTP were 0.818 and 0.847, respectively (p=0.459). The rate of uncertain diagnosis was significantly decreased in CICT sets (34.5% vs. 0%), and interobserver agreement was improved (k=0.527 vs. 0.718). On the CICT set, mean reading time was reduced by 49s and mean radiation dose was also decreased by 18.3% when replacing the non-contrast CT with CICT.
CONCLUSIONS: CICT is comparable to conventional liver CT protocol in demonstrating viable HCCs, while it allows a reduction in radiation dose.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23238365     DOI: 10.1016/j.ejrad.2012.11.014

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  9 in total

1.  Usefulness of fusion images of unenhanced and contrast-enhanced arterial phase cone-beam CT in the detection of viable hepatocellular carcinoma during transarterial chemoembolization.

Authors:  Eu Hyun Kim; Jung Suk Oh; Ho Jong Chun; Byung Gil Choi; Hae Giu Lee
Journal:  Diagn Interv Radiol       Date:  2018-09       Impact factor: 2.630

2.  Dual energy CT allows for improved characterization of response to antiangiogenic treatment in patients with metastatic renal cell cancer.

Authors:  K Hellbach; A Sterzik; W Sommer; M Karpitschka; N Hummel; J Casuscelli; M Ingrisch; M Schlemmer; A Graser; Michael Staehler
Journal:  Eur Radiol       Date:  2016-09-27       Impact factor: 5.315

Review 3.  Advanced CT techniques for assessing hepatocellular carcinoma.

Authors:  Yuko Nakamura; Toru Higaki; Yukiko Honda; Fuminari Tatsugami; Chihiro Tani; Wataru Fukumoto; Keigo Narita; Shota Kondo; Motonori Akagi; Kazuo Awai
Journal:  Radiol Med       Date:  2021-05-05       Impact factor: 3.469

4.  Iodine concentration as a perfusion surrogate marker in oncology: Further elucidation of the underlying mechanisms using Volume Perfusion CT with 80 kVp.

Authors:  Wolfgang M Thaiss; Ulrike Haberland; Sascha Kaufmann; Daniel Spira; Christoph Thomas; Konstantin Nikolaou; Marius Horger; Alexander W Sauter
Journal:  Eur Radiol       Date:  2015-12-17       Impact factor: 5.315

Review 5.  Dual-energy CT in diffuse liver disease: is there a role?

Authors:  Khaled Y Elbanna; Bahar Mansoori; Achille Mileto; Patrik Rogalla; Luís S Guimarães
Journal:  Abdom Radiol (NY)       Date:  2020-08-08

Review 6.  Recognizing and Minimizing Artifacts at Dual-Energy CT.

Authors:  Anushri Parakh; Chansik An; Simon Lennartz; Prabhakar Rajiah; Benjamin M Yeh; Frank J Simeone; Dushyant V Sahani; Avinash R Kambadakone
Journal:  Radiographics       Date:  2021-02-19       Impact factor: 5.333

Review 7.  Spectral detector CT applications in advanced liver imaging.

Authors:  Noor Fatima Majeed; Marta Braschi Amirfarzan; Christoph Wald; Jeremy R Wortman
Journal:  Br J Radiol       Date:  2021-05-28       Impact factor: 3.629

8.  Association between spectral computed tomography images and clinicopathological features in advanced gastric adenocarcinoma.

Authors:  Xiaohua Chen; Ke Ren; Pan Liang; Jiayin Li; Kuisheng Chen; Jianbo Gao
Journal:  Oncol Lett       Date:  2017-09-26       Impact factor: 2.967

Review 9.  Computed Tomography Techniques, Protocols, Advancements, and Future Directions in Liver Diseases.

Authors:  Naveen M Kulkarni; Alice Fung; Avinash R Kambadakone; Benjamin M Yeh
Journal:  Magn Reson Imaging Clin N Am       Date:  2021-08       Impact factor: 1.376

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.